The NHMRC-NIHR collaborative research grant scheme supports Australian participation and collaboration in leading international collaborative research through the UK’s NIHR Health Technology Assessment (HTA) Programme. The HTA Programme funds independent research about the effectiveness, costs and broader impact of healthcare treatments and tests. It includes a commissioned work stream which invites applications in response to calls for research on specific topics. Funding is for up to five years. In 2019, NHMRC has committed up to $3M to support the Australian components of projects that address the following research topics:
- 19/41 Clozapine for children and young people with treatment resistant schizophrenia
- 19/42 Selective serotonin reuptake inhibitor to prevent depression following traumatic brain injury
- 19/76 Antipsychotics for anorexia nervosa
- The Chief Investigator A (CIA) and their Administering Institution must be named as the Australian Partner Investigator on an application submitted to the NIHR
- The application must have been shortlisted based on scientific peer review by NIHR in order to be considered for funding by NHMRC
- Other Australian researchers listed on the NIHR application must be identified as CIs in the application to NHMRC
- Australian applicants must provide the Australian budget details on the NHMRC-NIHR Scheme application form (in RGMS).
The Australian applicants must be successful through the NIHR HTA process to be eligible to receive funding from NHMRC.
Submission requirements & due date
- Applications must be submitted for internal review by 18 March 2020
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an application to Research Services for review